📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines. (2022)

First Author: Grant E

Attributed to: SHeffield IMAging (SHIMA) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0268300

PubMed Identifier: 35617163

Publication URI: http://europepmc.org/abstract/MED/35617163

Type: Journal Article/Review

Volume: 17

Parent Publication: PloS one

Issue: 5

ISSN: 1932-6203